But the availability of generic versions of this pan-genotypic directly acting anti-viral (DAA) combination in India can be a boon for these uninsured patients as it costs about Rs 75,000 or about $1,200 or even less in India, just 1% of what the treatment cost in U.S. In fact even if the total cost of trip is calculated then also it won't come anyway near to